IPO
Soligenix, Inc. issued an update letter from its President and Chief Executive Officer, Dr. Christopher J. Schaber.
Eur 140 m bridge loan was drawn to secure evotec’s value chain expansion by successful acquisition of aptuit in august 2017
312 shareholders attended, representing 60% of the issued share capital
All investments in healthcare businesses progressing as planned to further accelerate growth
Conference Call and Webcast to Follow at 5:00 p.m. EDT / 2:00 p.m. PDT
The report summarises the business and highlights for 2018 and gives insights into the company’s strategy.
Promore Pharma AB calls for Annual General Meeting Tuesday 21 May 2019 at 2 pm at Wenner-Gren Center, Biblioteket, plan 24, Sveavägen 166, in Stockholm.
CEVEC Pharmaceuticals GmbH announced the successful closing of a Series D financing round with new and existing investors.
BioArctic AB announced that the Annual Report for the 2018 fiscal year has been published.
Auris Medical Holding Ltd. announced that the Nasdaq Hearings Panel has granted the Company’s request for the continued listing of the Company’s securities on The Nasdaq Capital Market.
PRESS RELEASES